Cited by

• Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus (MCMV).

  Katorza E, Pecht M, Apte RN, Benharroch D, Burstein Y, Trainin N, Rager-Zisman B. Katorza E, et al. Clin Exp Immunol. 1987 Nov;70(2):268-75. Clin Exp Immunol. 1987. PMID: 2448072 Free PMC article.
• Thymotaxin: a thymic epithelial peptide chemotactic for T-cell precursors.

  Imhof BA, Deugnier MA, Girault JM, Champion S, Damais C, Itoh T, Thiery JP. Imhof BA, et al. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7699-703. doi: 10.1073/pnas.85.20.7699. Proc Natl Acad Sci U S A. 1988. PMID: 3051002 Free PMC article.
• Zidovudine and thymus humoral factor gamma-2 in the treatment of HIV infection: preliminary clinical experience.

  Maggiolo F, Taras A, Pravettoni MG, Leone M, Ingrosso A, Suter F. Maggiolo F, et al. Infection. 1997 Jan-Feb;25(1):35-8. doi: 10.1007/BF02113505. Infection. 1997. PMID: 9039536 Clinical Trial.
• Therapy of a fatal murine cytomegalovirus infection with thymic humoral factor (THF-gamma 2) treated immune spleen cells.

  Rager-Zisman B, Zuckerman F, Benharroch D, Pecht M, Burstein Y, Trainin N. Rager-Zisman B, et al. Clin Exp Immunol. 1990 Feb;79(2):246-52. doi: 10.1111/j.1365-2249.1990.tb05186.x. Clin Exp Immunol. 1990. PMID: 2155728 Free PMC article.
• THF-gamma 2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil-treated mice bearing MOPC-315 plasmacytoma.

  Ophir R, Pecht M, Halperin D, Rashid G, Burstein Y, Ben-Efraim S, Trainin N. Ophir R, et al. Cancer Immunol Immunother. 1989;30(2):119-25. doi: 10.1007/BF01665963. Cancer Immunol Immunother. 1989. PMID: 2598178 Free PMC article.